Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hoff

Showing results (291-300 of 514) with videos related to

Pageof 52
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 26, 1998
Modulation of transgene expression in mesothelial cells by activation of an inducible promoterC M Hoff, J L Cusick, E M Masse, et al.
Clinical Colorectal Cancer|December 14, 2011
Literature review and practical aspects on the management of oxaliplatin-associated toxicityPaulo M Hoff, Everardo D Saad, Frederico Costa, et al.
American Journal of Human Genetics|June 1, 1993
A genome-wide search for genes predisposing to manic-depression, assuming autosomal dominant inheritanceH Coon, S Jensen, M Hoff, et al.
Plos One|June 1, 2014
Measuring social exclusion in routine public health surveys: construction of a multidimensional instrumentAddi P L van Bergen, Stella J M Hoff, Erik J C van Ameijden, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2009
Model-based prediction of phase III overall survival in colorectal cancer on the basis of phase II tumor dynamicsLaurent Claret, Pascal Girard, Paulo M Hoff, et al.
American Journal of Clinical Oncology|October 24, 2002
Phase II study of dolastatin-10 as first-line treatment for advanced colorectal cancerEverardo D Saad, Eric H Kraut, Paulo M Hoff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2000
Phase I assessment of the pharmacokinetics, metabolism, and safety of emitefur in patients with refractory solid tumorsJ Nemunaitis, R Eager, T Twaddell, et al.
American Journal of Medical Genetics|March 15, 1994
Analysis of chromosome 22 markers in nine schizophrenia pedigreesH Coon, J Holik, M Hoff, et al.
Ecancermedicalscience|October 6, 2015
Living better or living longer? Perceptions of patients and health care professionals in oncologyDiego de Araujo Toloi, Gabriela Critchi, Andrea Mangabeira, et al.
Cancer|August 12, 2006
Phase I study to determine the safety and pharmacokinetics of oral administration of TAS-102 in patients with solid tumorsDavid S Hong, James L Abbruzzese, Karla Bogaard, et al.
Pageof 52

Showing results (291-300 of 514) with videos related to

Sort By:
Pageof 52
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 26, 1998
Modulation of transgene expression in mesothelial cells by activation of an inducible promoterC M Hoff, J L Cusick, E M Masse, et al.
Clinical Colorectal Cancer|December 14, 2011
Literature review and practical aspects on the management of oxaliplatin-associated toxicityPaulo M Hoff, Everardo D Saad, Frederico Costa, et al.
American Journal of Human Genetics|June 1, 1993
A genome-wide search for genes predisposing to manic-depression, assuming autosomal dominant inheritanceH Coon, S Jensen, M Hoff, et al.
Plos One|June 1, 2014
Measuring social exclusion in routine public health surveys: construction of a multidimensional instrumentAddi P L van Bergen, Stella J M Hoff, Erik J C van Ameijden, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2009
Model-based prediction of phase III overall survival in colorectal cancer on the basis of phase II tumor dynamicsLaurent Claret, Pascal Girard, Paulo M Hoff, et al.
American Journal of Clinical Oncology|October 24, 2002
Phase II study of dolastatin-10 as first-line treatment for advanced colorectal cancerEverardo D Saad, Eric H Kraut, Paulo M Hoff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2000
Phase I assessment of the pharmacokinetics, metabolism, and safety of emitefur in patients with refractory solid tumorsJ Nemunaitis, R Eager, T Twaddell, et al.
American Journal of Medical Genetics|March 15, 1994
Analysis of chromosome 22 markers in nine schizophrenia pedigreesH Coon, J Holik, M Hoff, et al.
Ecancermedicalscience|October 6, 2015
Living better or living longer? Perceptions of patients and health care professionals in oncologyDiego de Araujo Toloi, Gabriela Critchi, Andrea Mangabeira, et al.
Cancer|August 12, 2006
Phase I study to determine the safety and pharmacokinetics of oral administration of TAS-102 in patients with solid tumorsDavid S Hong, James L Abbruzzese, Karla Bogaard, et al.
Pageof 52